PCIF1 anticorps
-
- Antigène Voir toutes PCIF1 Anticorps
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PCIF1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human PCIF1.
- Isotype
- IgG
-
-
- Indications d'application
- WB 1:500-1:2000 IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
- Autre désignation
- PCIF1 (PCIF1 Produits)
- Sujet
- Cap-specific adenosine methyltransferase that catalyzes formation of N(6),2'-O-dimethyladenosine cap (m6A(m)) by methylating the adenosine at the second transcribed position of capped mRNAs. Recruited to the early elongation complex of RNA polymerase II (RNAPII) via interaction with POLR2A and mediates formation of m6A(m) co-transcriptionally.
- Poids moléculaire
-
Observed_MW: 81 kDa
Calculated_MW: 81 kDa
- ID gène
- 63935
- UniProt
- Q9H4Z3
-